Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy

It has been intensively reported that the immunosuppressive tumor microenvironment (TME) results in tumor resistance to immunotherapy, especially immune checkpoint blockade and chimeric T cell antigen therapy. As an emerging therapeutic agent, oncolytic viruses (OVs) can specifically kill malignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yalei, Li, Ye, Chen, Kun, Qian, Ling, Wang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120729/
https://www.ncbi.nlm.nih.gov/pubmed/33985527
http://dx.doi.org/10.1186/s12935-021-01972-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120729/
https://www.ncbi.nlm.nih.gov/pubmed/33985527
http://dx.doi.org/10.1186/s12935-021-01972-2

Ejemplares similares